Medicare Enrolled
Dr. Jose Silva, MD
Medical Oncology · Chambersburg, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Silva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Silva?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Silva
Dr. Jose Silva is a medical oncology specialist in Chambersburg, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Silva performed 48,758 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Silva received a total of $14,115 from 36 pharmaceutical and/or device companies across 141 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Silva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 3% volume in PA
$14,115 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗48,758
Medicare services
Top 3% in PA for medical oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
13,500 | $1 | $4 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,500 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 6,200 | $43 | $97 |
| Paclitaxel chemotherapy injection | 5,520 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
4,880 | $6 | $20 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $19 | $34 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,921 | $21 | $124 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,836 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,050 | $1 | $34 |
| Anti-nausea injection (ondansetron/Zofran) | 520 | $0 | $30 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
379 | $2 | $14 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
314 | $12 | $111 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
307 | $96 | $240 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
300 | $2 | $8 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
276 | $112 | $595 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
265 | $11 | $52 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
242 | $99 | $455 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
182 | $22 | $207 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
135 | $48 | $174 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
116 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
106 | $21 | $124 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
96 | $7 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
95 | $66 | $160 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
90 | $137 | $365 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
82 | $55 | $138 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
79 | $49 | $264 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
74 | $1 | $4 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
58 | $20 | $61 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
38 | $16 | $207 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
38 | $40 | $255 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
38 | $1 | $8 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $10 | $207 |
| New patient office visit, complex (60-74 min) | 37 | $172 | $455 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
32 | $19 | $67 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
32 | $1 | $2 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
30 | $128 | $297 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
23 | $1 | $12 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $123 | $365 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $102 | $372 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $136 | $461 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
29.1% high complexity
69.4% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,115
Total received (2018-2024)
Avg $2,016/year across 7 years
Top 28% in PA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
141
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$91
2023
$180
2022
$3,530
2021
$830
2020
$261
2019
$7,392
2018
$1,831
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$91
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$5,965
Janssen Biotech, Inc.
$1,855
GlaxoSmithKline, LLC.
$1,625
R-Pharm US LLC
$1,320
AstraZeneca Pharmaceuticals LP
$578
Astellas Pharma US Inc
$535
E.R. Squibb & Sons, L.L.C.
$481
Pharmacyclics LLC, An AbbVie Company
$238
Novartis Pharmaceuticals Corporation
$177
Takeda Pharmaceuticals U.S.A., Inc.
$139
Merck Sharp & Dohme Corporation
$132
Sirtex Medical Inc
$128
Helsinn Therapeutics (U.S.), Inc.
$117
Exelixis Inc.
$97
Bayer HealthCare Pharmaceuticals Inc.
$78
Celgene Corporation
$70
Lilly USA, LLC
$65
PFIZER INC.
$64
GENZYME CORPORATION
$60
Eisai Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Genentech USA, Inc.
$40
TerSera Therapeutics LLC
$37
Amgen Inc.
$26
CTI BioPharma Corp.
$24
Rigel Pharmaceuticals, Inc.
$23
Seagen Inc.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15
Gilead Sciences, Inc.
$14
Seattle Genetics, Inc.
$12
Tactile Systems Technology Inc
$12
AbbVie, Inc.
$12
Acrotech Biopharma LLC
$12
Cumberland Pharmaceuticals, Inc.
$12
Taiho Oncology, Inc.
$11
Kyowa Kirin, Inc.
$11
Top 3 companies account for 66.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALOXI · Aliqopa · BELEODAQ · BLENREP · BOSULIF · CYRAMZA · Cabometyx · DARZALEX · Ethyol · FARESTON · FLEXITOUCH · GILOTRIF · Halaven · IMBRUVICA · IMFINZI · Imbruvica · Ixempra · JADENU · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · LYNPARZA · Lenvima · LifeVest · Lonsurf · MEKINIST · NINLARO · Neulasta · OPDIVO · Revlimid · Rezlidhia · SANDOSTATIN LAR · SARCLISA · SIR-Spheres Microspheres · SPRYCEL · TAGRISSO · TASIGNA · TECENTRIQ · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XOSPATA · XTANDI · Xofigo · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
1
County median income
$74,946
Nearest hospital to ZIP centroid (approximate)
WELLSPAN CHAMBERSBURG HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Silva is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Silva experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Silva performed 13,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Silva receive payments from pharmaceutical companies?
Yes. Dr. Silva received a total of $14,115 from 36 companies across 141 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Silva's costs compare to other medical oncologists in Chambersburg?
Dr. Silva's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Silva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Chambersburg
Browse medical oncologists in Chambersburg ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in PA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in PA
Which PA medical oncologists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology